Clinical trial
Evaluation of the Impact on Childhood Mortality of Azithromycin Plus Intermittent Preventive Treatment Administered Through the Expanded Program on Immunization in Sierra Leone
NCT04235816 is registered in ClinicalTrials.gov with Barcelona Institute for Global Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact on Childhood Mortality of Azithromycin Plus Intermittent Preventive Treatment Administered Through the Expanded Program on Immunization in Sierra Leone
- Lead sponsor
- Barcelona Institute for Global Health
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- March 15, 2021
- Completion date
- April 30, 2026
- Enrollment
- 20,560 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
child mortality